Literature DB >> 9182765

Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia.

S Mundlos1, F Otto, C Mundlos, J B Mulliken, A S Aylsworth, S Albright, D Lindhout, W G Cole, W Henn, J H Knoll, M J Owen, R Mertelsmann, B U Zabel, B R Olsen.   

Abstract

Cleidocranial dysplasia (CCD) is an autosomal-dominant condition characterized by hypoplasia/aplasia of clavicles, patent fontanelles, supernumerary teeth, short stature, and other changes in skeletal patterning and growth. In some families, the phenotype segregates with deletions resulting in heterozygous loss of CBFA1, a member of the runt family of transcription factors. In other families, insertion, deletion, and missense mutations lead to translational stop codons in the DNA binding domain or in the C-terminal transactivating region. In-frame expansion of a polyalanine stretch segregates in an affected family with brachydactyly and minor clinical findings of CCD. We conclude that CBFA1 mutations cause CCD and that heterozygous loss of function is sufficient to produce the disorder.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9182765     DOI: 10.1016/s0092-8674(00)80260-3

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  386 in total

1.  The gene for cherubism maps to chromosome 4p16.

Authors:  V Tiziani; E Reichenberger; C L Buzzo; S Niazi; N Fukai; M Stiller; H Peters; F M Salzano; C M Raposo do Amaral; B R Olsen
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

2.  Fibrodysplasia ossificans progressiva, a heritable disorder of severe heterotopic ossification, maps to human chromosome 4q27-31.

Authors:  G Feldman; M Li; S Martin; M Urbanek; J A Urtizberea; M Fardeau; M LeMerrer; J M Connor; J Triffitt; R Smith; M Muenke; F S Kaplan; E M Shore
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

3.  Involvement of the HLXB9 homeobox gene in Currarino syndrome.

Authors:  E Belloni; G Martucciello; D Verderio; E Ponti; M Seri; V Jasonni; M Torre; M Ferrari; L C Tsui; S W Scherer
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

Review 4.  Growth regulatory factors and bone.

Authors:  G R Mundy; D Chen; M Zhao; S Dallas; C Xu; S Harris
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

5.  Random monoallelic expression of three genes clustered within 60 kb of mouse t complex genomic DNA.

Authors:  Y Sano; T Shimada; H Nakashima; R H Nicholson; J F Eliason; T A Kocarek; M S Ko
Journal:  Genome Res       Date:  2001-11       Impact factor: 9.043

6.  A novel dysmorphic syndrome with open calvarial sutures and sutural cataracts maps to chromosome 14q13-q21.

Authors:  Simeon A Boyadjiev; Cristina M Justice; Wafaa Eyaid; Victor A McKusick; Ralph S Lachman; Arnab B Chowdry; Monzer Jabak; Johan Zwaan; Alexander F Wilson; Ethylin Wang Jabs
Journal:  Hum Genet       Date:  2003-04-03       Impact factor: 4.132

7.  In vivo analysis of a developmental circuit for direct transcriptional activation and repression in the same cell by a Runx protein.

Authors:  Jude Canon; Utpal Banerjee
Journal:  Genes Dev       Date:  2003-04-01       Impact factor: 11.361

8.  Immortalized mouse floxed Bmp2 dental papilla mesenchymal cell lines preserve odontoblastic phenotype and respond to BMP2.

Authors:  Li-an Wu; Junsheng Feng; Lynn Wang; Yan-dong Mu; Andrew Baker; Kevin J Donly; Jelica Gluhak-Heinrich; Stephen E Harris; Mary MacDougall; Shuo Chen
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

9.  Novel HOXA13 mutations and the phenotypic spectrum of hand-foot-genital syndrome.

Authors:  F R Goodman; C Bacchelli; A F Brady; L A Brueton; J P Fryns; D P Mortlock; J W Innis; L B Holmes; A E Donnenfeld; M Feingold; F A Beemer; R C Hennekam; P J Scambler
Journal:  Am J Hum Genet       Date:  2000-06-05       Impact factor: 11.025

10.  Serine phosphorylation of RUNX2 with novel potential functions as negative regulatory mechanisms.

Authors:  Hee-Jun Wee; Gang Huang; Katsuya Shigesada; Yoshiaki Ito
Journal:  EMBO Rep       Date:  2002-09-13       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.